Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation
Similarly, the SURMOUNT-1 trial demonstrated that participants receiving tirzepatide 15 mg weekly lost approximately 20.9% of body weight, with lean mass comprising roughly 25-30% of total loss based on available data
Establish a relaxing bedtime routine, such as reading or taking a warm bath
Large telehealth providers (e.g., Ro, WeightWatchers, and Hims & Hers) that have pivoted from compounded GLP-1s are repositioning as broader obesity care platforms, combining authorized access to branded GLP-1s with coaching, nutrition support, and adherence tools
Glucagon-like peptide-1 (GLP-1) medications, widely known for their effectiveness in promoting weight loss in individuals struggling with obesity and type 2 diabetes, are showing promising new potential benefits beyond metabolic health
WegebergAL,HansenCS,FarmerAD,etal.Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double-blind, placebo-controlled trial.United European Gastroenterol J.2020;8(6):695704